Learn more

ACELL INC

Overview
  • Total Patents
    108
  • GoodIP Patent Rank
    26,234
  • Filing trend
    ⇧ 42.0%
About

ACELL INC has a total of 108 patent applications. It increased the IP activity by 42.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are EDIXOMED LTD, DICOSMO FRANK and BIOLOGICA TECH.

Patent filings per year

Chart showing ACELL INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Fette Clay 30
#2 Spievack Alan R 26
#3 Bosley Jr Rodney W 18
#4 Janis Abram D 16
#5 Stuart Katherine A 16
#6 Tullius Robert S 16
#7 Kentner Kimberly A 15
#8 Badylak Stephen F 11
#9 Janis Abram 11
#10 Kibalo Benjamin 11

Latest patents

Publication Filing date Title
US2018280574A1 Extracellular matrix compositions with bactericidal or bacteriostatic characteristics useful for protecting and treating patients with bacterial infections
WO2016048946A1 Porous foams derived from extracellular matrix, porous foam ecm medical devices, and methods of use and making thereof
KR20170070268A Methods of manufacturing bioactive gels from extracellular matrix material
AU2013201872A1 Particulate tissue graft with components of differing density and methods of making and using the same
AU2012347804A1 Hemostatic device
WO2011011482A2 Variable density tissue graft composition and methods of making and using the same
KR20180082627A Particulate tissue graft with components of differing density and methods of making and using the same
TW201109045A Adhesive patch, tissue transplantation frame, tissue regeneration device and the structure thereof
AU2004253508A1 Conditioned matrix compositions for tissue restoration
US2004175366A1 Scaffold for cell growth and differentiation
US2004176855A1 Decellularized liver for repair of tissue and treatment of organ deficiency
WO0145765A1 Tissue regenerative composition
US6576265B1 Tissue regenerative composition, method of making, and method of use thereof
US6579538B1 Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof